Blevins v. Wyeth-Ayerst Labs

Summary of Case and Settlement:

No. 324380 (Sup. Ct. San Francisco Cty. CA). Plaintiff alleged that Wyeth-Ayerst unlawfully monopolized the market for conjugated estrogen drug products through exclusive contracts with health benefit providers and pharmacy benefit managers. On October 30, 2007, the court approved a $5.2 million settlement for a class of California purchasers of Wyeth-Ayerst’s conjugated estrogen drug product.

Contact Us

First Name

Last Name



Case This Inquiry Relates To